down arrow

Modern Chinese Medicine Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG6181B1068
HKD
0.50
-0.03 (-5.66%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Lee's Pharmaceutical Holdings Ltd.
Pak Fah Yeow International Ltd.
Modern Chinese Medicine Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Antengene Corp. Ltd.
Clover Biopharmaceuticals Ltd.
China Biotech Services Holdings Ltd.
CANbridge Pharmaceuticals Inc.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Lansen Pharmaceutical Holdings Ltd.
Tianda Pharmaceuticals Ltd.
Why is Modern Chinese Medicine Group Co., Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
2
The company has declared Negative results for the last 4 consecutive quarters
  • ROCE(HY) Lowest at 2.03%
  • DEBT-EQUITY RATIO (HY) Highest at -47.8 %
  • RAW MATERIAL COST(Y) Grown by 42.25% (YoY)
3
With ROE of 2.04%, it has a Very Expensive valuation with a 0.82 Price to Book Value
  • Over the past year, while the stock has generated a return of 7.53%, its profits have fallen by -80.6%
4
Underperformed the market in the last 1 year
  • The stock has generated a return of 7.53% in the last 1 year, much lower than market (Hang Seng Hong Kong) returns of 27.36%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Modern Chinese Medicine Group Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Modern Chinese Medicine Group Co., Ltd.
7.53%
0.41
81.27%
Hang Seng Hong Kong
27.36%
1.06
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-22.26%
EBIT Growth (5y)
-45.52%
EBIT to Interest (avg)
97.34
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.74
Tax Ratio
34.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
52.73%
ROE (avg)
14.49%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
0.81
EV to EBIT
6.70
EV to EBITDA
4.82
EV to Capital Employed
0.65
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.64%
ROE (Latest)
2.04%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Modern Chinese Medicine Group Co., Ltd.
Net Profit
Higher at HKD 17.92 MM
than preceding 12 month period ended Dec 2024
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Depreciation
Highest at HKD 6.73 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation
At HKD 6.73 MM has Grown at 102.21%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Modern Chinese Medicine Group Co., Ltd.
Debt-Equity Ratio
Highest at -47.8 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv
Lowest at HKD 246.49 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 4.12%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 2.22%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 42.25% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."